← Back to Search

Triple-Masking vs Double-Masking for Publication Bias (TripleMasking Trial)

N/A

Recruiting

Led By ALFREDO MORABIA

Research Sponsored by Queens College, The City University of New York

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Timeline

Screening 3 weeks

Treatment Varies

Follow Up full duration of the study, 6 months, from september 5 2023 to march 1 2024

Awards & highlights

TripleMasking Trial Summary

This trial is testing if hiding the identity of authors and reviewers from editors and each other will lead to less bias in scientific journal acceptance.

Who is the study for?

This trial is for authors submitting new research articles, notes from the field, non-commissioned editorials, analytic essays, and systematic reviews to the American Journal of Public Health. It excludes resubmissions or submissions like commissioned editorials, book reviews, letters to the editor.Check my eligibility

What is being tested?

The study tests if hiding author and reviewer identities from editors (triple-masking) affects editorial decisions compared to just hiding identities between authors and reviewers (double-masking). The goal is to see if triple-masking reduces bias in accepting articles for publication.See study design

What are the potential side effects?

Since this trial involves manuscript review processes rather than medical interventions, it does not have side effects in the traditional sense. However, outcomes may include changes in acceptance rates due to reduced bias.

TripleMasking Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ full duration of the study, 6 months, from september 5 2023 to march 1 2024

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~full duration of the study, 6 months, from september 5 2023 to march 1 2024

This trial's timeline: 3 weeks for screening, Varies for treatment, and full duration of the study, 6 months, from september 5 2023 to march 1 2024 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Difference in the proportion of manuscripts submitted within the six-month window that are accepted for publication (i.e., not rejected at any stage); risk difference, unadjusted

Secondary outcome measures

TripleMasking Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Triple-MaskedExperimental Treatment1 Intervention

For articles allocated to the blinded (masked) editorial process, the editorial assistant will delete identifiable/unmasking content of cover page and letters. All articles will be flagged as being in triplemasked editorial process arm in the document title

Group II: Usual ProceduresActive Control1 Intervention

All articles will be flagged as being in usual editorial process arm in the document title. For articles allocated to the usual (double-masked) editorial process, the editorial assistant will leave identifiable/unmasking content of cover page and letters for the editors.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Queens College, The City University of New YorkLead Sponsor

12 Previous Clinical Trials

9,787 Total Patients Enrolled

ALFREDO MORABIAPrincipal InvestigatorQueens College, The City University of New York

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the aggregate patient count for this clinical investigation?

"Correct. The information on clinicaltrials.gov attests that this medical investigation is currently looking for volunteers; it was originally posted 9/6/2023 and its most recent update occurred 10/2/2023. 1500 participants need to be enlisted from a single medical site."

Answered by AI

Are medical professionals looking for volunteers for this clinical trial?

"Affirmative. Per the clinicaltrials.gov database, recruitment for this trial is ongoing since its inception on September 6th 2023 and most recent update on October 2nd of the same year. Currently, 1500 individuals are being sought across a single site."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Triple-masking v Double-masking: a Trial of Scientific Publication in Public Health

2023. "Triple-masking v Double-masking: a Trial of Scientific Publication in Public Health". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06067633.